Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: Case report, "what worked and what did not"

BMC Nephrology

Volumn 8, Issue , 2007, Pages

  Volkow, Patricia ^a   Zinser, Juan W ^a   Correa Rotter, Ricardo ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; PREDNISONE; RAPAMYCIN; VINCRISTINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AGED; AGRANULOCYTOSIS; ANASARCA; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; CREATININE BLOOD LEVEL; DETERIORATION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG WITHDRAWAL; GRANULOCYTOPENIA; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEG EDEMA; LEG PAIN; MALE; MOLECULAR THERAPY; ORGAN DONOR; PNEUMONIA; SIDE EFFECT; CANCER STAGING; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; IMMUNOHISTOCHEMISTRY; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; RETREATMENT; RISK ASSESSMENT; SKIN TUMOR; TREATMENT OUTCOME;

AGED, 80 AND OVER; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; NEOPLASM STAGING; PIPERAZINES; PYRIMIDINES; RETREATMENT; RISK ASSESSMENT; SARCOMA, KAPOSI; SIROLIMUS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34247107202     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-8-6     Document Type: Article

References (18)

1. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Y Chang E Cesarman MS Pessin F Lee J Culpepper DM Knowles PS Moore, Science 1994 266 5192 1865 9 10.1126/science.7997879 7997879
2. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. YQ Huang JJ Li MH Kaplan B Poiesz E Katabira WC Zhang D Feiner AE Friedman-Kien, Lancet 1995 345 8952 759 61 10.1016/S0140-6736(95)90641-X 7891487
3. Kaposi's Sarcoma. K Antman Y Chang, New Engl J Med 2000 342 1027 1038 10.1056/NEJM200004063421407 10749966
4. Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma. HB Koon GJ Bubley L Pantanowitz D Masiello B Smith K Crosby J Proper W Weeden TE Miller P Chatis MJ Egorin SR Tahan BJ Dezube, J Clin Oncol 2004 23 1 8 10.1200/JCO.2005.06.079 15545667
5. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. G Stallone A Schena B Infante S Di Paolo A Loverre G Maggio E Ranieri L Gesualdo FP Schena G Grandaliano, N Engl J Med 2005 352 13 1317 23 10.1056/NEJMoa042831 15800227
6. Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia. A Quintas-Cardama H Kantarjian S O'Brien G Garcia-Manero MB Rios M Talpaz J Cortes, Cancer 2004 100 12 2592 7 10.1002/cncr.20285 15197801
7. Long-term remission of Kaposi's sarcoma in AIDS patients after ganciclovir therapy. P Volkow J Zinser, Proceedings of ASCO Vol 2000 2265 575a
8. KSHV, Kaposi's Sarcoma, and related lymphoproliferative disorders. Y Chang, Infection as a cause of human cancers Oxford University Press. New York USA, Parsonnet J Microbes, Malignancies, 1999 207 231
9. The appearance of Kaposi sarcoma during corticosteroid therapy. A Trattner E Hodak M David M Sandbank, Cancer 1993 72 5 1779 83 10.1002/1097-0142(19930901)72:5〈1779::AID-CNCR2820720543〉3.0.CO;2-M 8348508
10. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma. WX Guo T Antakly M Cadotte Z Kachra L Kunkel R Masood P Gill, Am J Pathol 1996 148 6 1999 2008 8669484
11. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. WX Guo T Antakly, Am J Pathol 1995 146 3 727 34 7887453
12. Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids. A Trattner E Hodak M David A Neeman M Sandbank, J Am Acad Dermatol 1993 29 5 Pt 2 890 4 8408835
13. Kaposi's sarcoma complicating long-term corticotherapy for severe asthma. A Bruet A Mahe JF Sei C Mathe C Felsenheld L Lechevalier JP Fendler, Rev Med Interne 1990 11 4 322 4 2096440
14. Non-AIDS-associated Kaposi's sarcoma (classical and endemic African types):treatment with low doses of recombinant interferon-alpha. M Rybojad L Borradori O Verola J Zeller A Puissant P Morel, J Invest Dermatol 1990 95 6 Suppl 176S 179S 2258634
15. Classic (non-AIDS-related) Kaposi's sarcoma in a Japanese patient, successfully treated with alpha-2b-interferon. S Shimizu M Tanaka H Niizeki S Miyakawa A Ishiko H Shimizu, Br J Dermatol 1995 133 2 332 4 10.1111/j.1365-2133. 1995.tb02646.x 7547414
16. Therapeutic strategies for epidemic Kaposi's sarcoma. M Aldenhoven NP Barlo CJ Sanders, Int J STD AIDS 2006 17 9 571 8 10.1258/095646206778113131 16942647
17. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. JM Campistol A Gutiérrez-Dalmau JV Torregrosa, Transplantation 2004 77 5 760 2 10.1097/01.TP.0000115344.18025.0B 15021843
18. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. SC Zmonarski M Boratynska J Rabczynski K Kazimierczak M Klinger, Transplant Proc 2005 37 2 964 6 10.1016/j.transproceed.2004.12.172 15848592